Bio-Rad Introduces the New ZOE™ Fluorescent Cell Imager

Date: 
2014-09-29

Fluorescence Microscopy Now as Easy as Using a Tablet

Hercules, CA — September 29, 2014 — Bio-Rad Laboratories, Inc. (NYSE BIO and BIOb) today announced the launch of the ZOE™ Fluorescent Cell Imager, one of the first cell imaging systems able to deliver the power of microscopy in a system that is as easy to use as a tablet. The system includes three fluorescent channels and brightfield to simplify fluorescence imaging for cell culture applications.

Fluorescence microscopes are used in traditional cell culture workflows to confirm transfection efficiency and visualize fluorescent proteins. Performing this task requires training and the process can be time-consuming. Fluorescence microscopes can take 15 minutes to warm up and the systems are often located in a separate facility that is outfitted with a darkroom.

The ZOE Fluorescent Cell Imager makes fluorescence imaging easy, fast, and intuitive.

However, the ZOE Fluorescent Cell Imager’s LEDs are instantly ready to use after the power is turned on. Researchers simply place their culture dish onto ZOE’s stage and then access all controls using the LCD touch screen, tapping the screen to capture images and pinching with their fingers to zoom up to 20x magnification. Outfitted with a light shield, ZOE enables users to perform fluorescence experiments in ambient light on their lab benchtop, eliminating the need for a dedicated darkroom.

“Users report they turn on ZOE and know immediately what to do, even those who are imaging cell fluorescence for the first time,” said Veronika Kortisova-Descamps, Bio-Rad product manager, Cell Biology.

Additional Benefits of ZOE

  • Multichannel fluorescence — detection of fluorescence emission at blue, green, and red wavelengths is accomplished with three fluorescence channels optimized for commonly used fluorophores
  • Large field of view — motorized stage and large field of view (0.70 mm2) enable researchers to see more of their sample, faster
  • Manipulate and store images on hard drive — users can merge images for co-expression experiments and store up to 12 GB of image files for export to a USB flash drive

Please visit www.bio-rad.com/ZOEpr for more information about Bio-Rad’s new ZOE Fluorescent Cell Imager.

About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) develops, manufactures, and markets a broad range of innovative products and solutions for the life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 100,000 research and healthcare industry customers through its global network of operations. The company employs approximately 7,750 people worldwide and had revenues exceeding $2.1 billion in 2013. For more information, visit our website at www.bio-rad.com.

This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally can be identified by the use of forward-looking terminology such as, “believe,” “expect,” “may,” “will,” “intend,” “estimate,” “continue,” or similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. For further information regarding the Company's risks and uncertainties, please refer to the “Risk Factors” in the Company’s public reports filed with the Securities and Exchange Commission, including the Company’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company cautions you not to place undue reliance on forward-looking statements, which reflect an analysis only and speak only as of the date hereof. Bio-Rad Laboratories, Inc., disclaims any obligation to update these forward-looking statements.

For more information contact:
Steve Kulisch
Bio-Rad Laboratories, Inc.
510-741-5638
Steve_Kulisch@bio-rad.com

Ken Li
Chempetitive Group
312-997-2436 x112
kli@chempetitive.com